Dr. Günter Ditzinger has more than 30 years of pharmaceutical innovation experience spanning early development to product launch at Sanofi and subsequently Novartis.
Before joining UNION in 2020, Günter was Chief Technology Officer at Basilea Pharmaceutica, where he was responsible for pharmaceutical, chemical and analytical development as well as the commercial supply chain at the global level. Günter has played vital roles in the successful development and commercial launch of multiple marketed products: Toctino® in chronic hand eczema, Zevtera® in bacterial infections, and Cresemba® in systemic fungal Infections.
Günter is a Registered Pharmacist and holds a Ph.D. in Pharmaceutical Technology from Goethe University in Frankfurt/Main, Germany.
